RNA Editing Modulates Human Hepatic Aryl Hydrocarbon Receptor Expression by Creating MicroRNA Recognition Sequence*

Adenosine to inosine (A-to-I) RNA editing is the most frequent type of post-transcriptional nucleotide conversion in humans, and it is catalyzed by adenosine deaminase acting on RNA (ADAR) enzymes. In this study we investigated the effect of RNA editing on human aryl hydrocarbon receptor (AhR) expression because the AhR transcript potentially forms double-stranded structures, which are targets of ADAR enzymes. In human hepatocellular carcinoma-derived Huh-7 cells, the ADAR1 knockdown reduced the RNA editing levels in the 3′-untranslated region (3′-UTR) of the AhR transcript and increased the AhR protein levels. The ADAR1 knockdown enhanced the ligand-mediated induction of CYP1A1, a gene downstream of AhR. We investigated the possibility that A-to-I RNA editing creates miRNA targeting sites in the AhR mRNA and found that the miR-378-dependent down-regulation of AhR was abolished by ADAR1 knockdown. These results indicated that the ADAR1-mediated down-regulation of AhR could be attributed to the creation of a miR-378 recognition site in the AhR 3′-UTR. The interindividual differences in the RNA editing levels within the AhR 3′-UTR in a panel of 32 human liver samples were relatively small, whereas the differences in ADAR1 expression were large (220-fold). In the human liver samples a significant inverse association was observed between the miR-378 and AhR protein levels, suggesting that the RNA-editing-dependent down-regulation of AhR by miR-378 contributes to the variability in the constitutive hepatic expression of AhR. In conclusion, this study uncovered for the first time that A-to-I RNA editing modulates the potency of xenobiotic metabolism in the human liver.

[1]  S. Kyo,et al.  Human CYP1B1 is regulated by estradiol via estrogen receptor. , 2004, Cancer research.

[2]  Qiang Ma,et al.  2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced Degradation of Aryl Hydrocarbon Receptor (AhR) by the Ubiquitin-Proteasome Pathway , 2000, The Journal of Biological Chemistry.

[3]  Kol Jia Yong,et al.  A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma , 2013, Gut.

[4]  C. Jung,et al.  Fisetin protects against hepatosteatosis in mice by inhibiting miR-378. , 2013, Molecular nutrition & food research.

[5]  O. Gotoh,et al.  Interindividual difference in expression of human Ah receptor and related P450 genes. , 1994, Carcinogenesis.

[6]  X. Coumoul,et al.  Aryl hydrocarbon receptor-dependent induction of liver fibrosis by dioxin. , 2014, Toxicological sciences : an official journal of the Society of Toxicology.

[7]  K. Hayakawa,et al.  Induction of CYP1A1, CYP1A2, and CYP1B1 mRNAs by nitropolycyclic aromatic hydrocarbons in various human tissue-derived cells: chemical-, cytochrome P450 isoform-, and cell-specific differences , 2002, Archives of Toxicology.

[8]  Kazuko Nishikura,et al.  Adenosine-to-inosine RNA editing and human disease , 2013, Genome Medicine.

[9]  Zipora Y. Fligelman,et al.  Systematic identification of abundant A-to-I editing sites in the human transcriptome , 2004, Nature Biotechnology.

[10]  J. Qian,et al.  MiR-378 Promotes the Migration of Liver Cancer Cells by Down-Regulating Fus Expression , 2014, Cellular Physiology and Biochemistry.

[11]  P. Seeburg,et al.  Modulation of microRNA processing and expression through RNA editing by ADAR deaminases , 2006, Nature Structural &Molecular Biology.

[12]  L. Landweber,et al.  Hypothesis: RNA editing of microRNA target sites in humans? , 2007, RNA.

[13]  S. Maas,et al.  Molecular diversity through RNA editing: a balancing act. , 2010, Trends in genetics : TIG.

[14]  A. Gallo,et al.  A-to-I RNA editing and cancer: From pathology to basic science , 2008, RNA biology.

[15]  T. Mikkelsen,et al.  Altered adenosine-to-inosine RNA editing in human cancer. , 2007, Genome research.

[16]  J. E. Smith,et al.  A double-stranded RNA unwinding activity introduces structural alterations by means of adenosine to inosine conversions in mammalian cells and Xenopus eggs. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Yasuhiro Aoki,et al.  Human CYP2E1 is regulated by miR-378. , 2010, Biochemical pharmacology.

[18]  C. Samuel,et al.  Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: evidence for two forms of the deaminase , 1995, Molecular and cellular biology.

[19]  Yanhong Tai,et al.  ADAR1 regulates ARHGAP26 gene expression through RNA editing by disrupting miR-30b-3p and miR-573 binding , 2013, RNA.

[20]  M. Carmo-Fonseca,et al.  Dynamic association of RNA-editing enzymes with the nucleolus , 2003, Journal of Cell Science.

[21]  K. A. Lehmann,et al.  Double-stranded RNA adenosine deaminases ADAR1 and ADAR2 have overlapping specificities. , 2000, Biochemistry.

[22]  A. Källman,et al.  ADAR2 A-->I editing: site selectivity and editing efficiency are separate events. , 2003, Nucleic acids research.

[23]  E. Levanon,et al.  Genome-wide analysis of Alu editability , 2014, Nucleic acids research.

[24]  D. Bartel MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[25]  H. McLeod,et al.  Single-Nucleotide Polymorphisms in Cytochrome P450 2E1 (CYP2E1) 3′-Untranslated Region Affect the Regulation of CYP2E1 by miR-570 , 2015, Drug Metabolism and Disposition.

[26]  B. Bass,et al.  Preferential selection of adenosines for modification by double‐stranded RNA adenosine deaminase. , 1994, The EMBO journal.

[27]  K. Nishikura,et al.  Molecular cloning of cDNA for double-stranded RNA adenosine deaminase, a candidate enzyme for nuclear RNA editing. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[28]  K. Nishikura Functions and regulation of RNA editing by ADAR deaminases. , 2010, Annual review of biochemistry.

[29]  Wenwei Zhang,et al.  Comprehensive analysis of RNA-Seq data reveals extensive RNA editing in a human transcriptome , 2012, Nature Biotechnology.

[30]  P. Sethupathy,et al.  Inhibition of miR-29 has a significant lipid-lowering benefit through suppression of lipogenic programs in liver , 2015, Scientific Reports.

[31]  P. Seeburg,et al.  A standardized nomenclature for adenosine deaminases that act on RNA. , 1997, RNA.

[32]  G. Perdew,et al.  Role of the aryl hydrocarbon receptor in drug metabolism , 2005, Expert opinion on drug metabolism & toxicology.

[33]  T. Luedde,et al.  Micro‐RNA profiling reveals a role for miR‐29 in human and murine liver fibrosis , 2011, Hepatology.

[34]  Jochen C. Hartner,et al.  Specificity of ADAR-mediated RNA editing in newly identified targets. , 2008, RNA.

[35]  Leilei Chen,et al.  Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma , 2013, Nature Medicine.

[36]  R. Pollenz,et al.  Aryl Hydrocarbon Receptor Imported into the Nucleus following Ligand Binding Is Rapidly Degraded via the Cytosplasmic Proteasome following Nuclear Export* , 1999, The Journal of Biological Chemistry.

[37]  A. Hatzigeorgiou,et al.  Redirection of Silencing Targets by Adenosine-to-Inosine Editing of miRNAs , 2007, Science.

[38]  Vivian G. Cheung,et al.  ADAR Regulates RNA Editing, Transcript Stability, and Gene Expression , 2013, Cell reports.

[39]  W. Keller,et al.  Two forms of human double-stranded RNA-specific editase 1 (hRED1) generated by the insertion of an Alu cassette. , 1997, RNA.

[40]  W. Paschen,et al.  RNA Editing of Glutamate Receptor Subunits GluR2, GluR5, and GluR6 in Transient Cerebral Ischemia in the Rat , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[41]  Molly Megraw,et al.  Frequency and fate of microRNA editing in human brain , 2008, Nucleic acids research.

[42]  Yi Xing,et al.  Adenosine deamination in human transcripts generates novel microRNA binding sites , 2009, Human molecular genetics.